Insider · CIK 0001303609
Frank E Jaumot
Files at NUTX (Nutex Health, Inc.). First filing Mar 23, 2026, latest Mar 23, 2026.
In brief
Frank E Jaumot files SEC Form 4 as director at NUTX (Nutex Health, Inc.). Since Mar 23, 2026, Frank E Jaumot has reported 1 open-market buy worth $14k and 0 open-market sells worth $0, the latest filed on Mar 23, 2026.
A track record needs three past buys with six months of prices behind them; Frank E Jaumot has 0, so none is measured yet.
The newest scored trade: bought $14k of NUTX on Mar 20, 2026, filed Mar 23, 2026, scored 46 (moderate). In the last 12 months: 1 buy worth $14k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NUTX: Nutex Health, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | Nutex Health, Inc. | $14k 150 shares | - | +89% from low-53% from high |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | NUTX Nutex Health, Inc. | MOption exercise Common Stock | +603 | $0.00 | $0 | 753 | Aug 3, 2026 |
| Apr 23, 2026 | NUTX Nutex Health, Inc. | AGrant or award Restricted Stock Units (RSUs)derivative | +823 | $0.00 | $0 | 1,426 | Apr 24, 2026 |
| Mar 20, 2026 | NUTX Nutex Health, Inc. | POpen-market purchase Common Stock | +150 | $93.56 | $14k | 150 | Mar 23, 2026 |
| Jul 14, 2025 | NUTX Nutex Health, Inc. | AGrant or award Restricted Stock Units (RSUs)derivative | +603 | $0.00 | $0 | 603 | Feb 9, 2026 |
Questions about Frank E Jaumot
Answered from the filings on this page, as of the latest one.
Is Frank E Jaumot buying or selling?
In the last 12 months Frank E Jaumot reported 1 open-market buy worth $14k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $14k of NUTX on Mar 20, 2026. Grants, option exercises and tax withholding are not counted.
How did Frank E Jaumot's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Frank E Jaumot has 0.
Where does Frank E Jaumot file Form 4?
Frank E Jaumot has filed Form 4 at NUTX (Nutex Health, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.